Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (d) On November 10, 2025, the Board of Directors (the “Board”) of Sensus Healthcare, Inc. (the “Company”) appointed Eric Sachetta as a Class II director of the Company for a term expiring at the Company’s annual meeting in 2026. Mr.…
Filed Nov 13, 2025Accepted Nov 13, 2025, 10:06 AM ESTCIK 1494891Accession 0001753926-25-001772
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
ITEM
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
(d)
On
November 10, 2025, the Board of Directors (the “Board”) of Sensus Healthcare, Inc. (the “Company”) appointed
Eric Sachetta as a Class II director of the Company for a term expiring at the Company’s annual meeting in 2026. Mr.
Sachetta fills a vacancy resulting from the death of William McCall.
Mr.
Sachetta, age 37, is Chief Wealth Services Officer of Sachetta, LLC, a financial advisory firm founded by Mr. Sachetta. In that
role, his responsibilities include leading and managing the firm’s financial advisory division and overseeing all wealth
management operations and advisor development. Before assuming his current position in 2022, he held other positions with the
firm from 2016. Mr. Sachetta’s previous employment included serving as a leadership speaker and author and as a district
manager of a marketing organization. He is a Certified Financial Planner® and holds other licenses and certifications. Mr.
Sachetta received a bachelor’s degree in Corporate Finance and Accounting from Bentley University.
There
are no arrangements or understandings between Mr. Sachetta and any other persons pursuant to which he was elected, nor does
he have any direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Securities
and Exchange Commission Regulation S-K. As a director of the Company, Mr. Sachetta is expected to receive the same compensation
for service as a director as is provided to other non-employee directors of the Company on a pro-rata annual
basis. The Board has determined that Mr. Sachetta is an independent director within the meaning of Rule 5605(a)(2) as
set forth in the listing standards of The NASDAQ Stock Market, LLC. Mr. Sachetta has been appointed as a member
of the Audit Committee of the Board.
On
November 12, 2025, the Company issued a press release announcing Mr. Sachetta’s election. The press release is filed as
an exhibit to this Report. The press release shall not be deemed "filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except
as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) g085016_ex99-1.htm
EX-99.1
2
g085016_ex99-1.htm
EXHIBIT 99.1
Exhibit 99.1
Sensus
Healthcare Appoints Eric Sachetta to its Board of Directors
Seasoned
financial executive brings leadership acumen, strategic growth expertise and a strong track record of operational excellence
BOCA
RATON, Fla. (November 12, 2025) - Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,
non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the
appointment of Eric Sachetta to the Company’s Board of Directors. Mr. Sachetta is filling the vacancy that resulted from
the passing of long-serving Director Bill McCall.
Throughout
his career, Mr. Sachetta has held a range of leadership roles focused on organizational growth, team development, sales performance and
operational improvement. He currently serves as Chief Wealth Services Officer of Sachetta, LLC, a financial advisory firm based
in Lynnfield, Mass., where he leads firmwide advisory strategy, operational oversight, financial planning innovation and multi-disciplinary
client service execution. Since 2022, he has led and managed the firm’s fi…